NCT03831230View on ClinicalTrials.gov

Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response

CompletedOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

March 7, 2019

Primary Completion Date

February 27, 2025

Study Completion Date

February 27, 2025

Conditions

Ovarian Cancer

Interventions

GENETIC

collection of blood, urine, tumor and ascite samples

collection of blood, urine, tumor and ascite samples during ovarian surgery

Trial Locations (1)

Unknown

Centre François BACLESSE, Caen

All Listed Sponsors

lead

Centre Francois Baclesse

OTHER

NCT03831230 - Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response | Biotech Hunter | Biotech Hunter